Fritextsökning
Innehållstyper
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Medicon Valley cluster in brief
The Medicon Valley covers the Öresund region (Skåne and Sjaelland).
-
Denator stärker närvaron i Asien
Göteborgsbolaget har utsett Aspec Technologies Limited och D.I Biotech Ltd. till nya distributörer på utvalda marknader i Asien.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
Cell incubator with built-in microscope
InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
49 miljoner till dengueforskning
Umeå universitet får ett rekordstort EU-anslag. Pengarna innebär att lärosätet nu kan profilera sig inom forskning om klimatförändringar och hälsa.
-
Satsar på två marknader
Göteborgsbaserade Albireos förhoppning med nya dotterbolaget i Boston är att kunna dra nytta av båda marknader i sin utveckling till ett globalt läkemedelsbolag.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Diamyd Medicals styrelse bemöter förslaget om likvidation
"De har gjort en dålig affär och vill ha pengarna tillbaka".
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
USA vill öka transparensen
Vill ändra lagstiftningen för öka mängden tillgänglig information från kliniska studier.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
A crash course in IP strategy
"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...
-
With their hands on the legal levers
It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Proteinkartan uppdateras
Den nya versionen av Human Protein Atlas innehåller en uppdaterad karta över proteindistributionen i mushjärnan och en validering av de antikroppar som använts i projektet.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Så ska läkemedelsplattformen hjälpa forskarna
Om några veckor öppnar Scilifelabs Drug Discovery and Development-plattform. Här ska forskarna i akademin få hjälp att ta fram substanser som kan utvecklas till...
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Medicult needs a word of advice
Medicult Board retains advisers, regarding the previous offer from Vitrolife.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...